AFYX THERAPEUTICS

Serial Number 88279875
Registration 5987801
700

Registration Progress

Application Filed
Jan 28, 2019
Under Examination
Oct 1, 2019
Approved for Publication
Aug 6, 2019
Published for Opposition
Aug 6, 2019
Registered
Feb 18, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-02-18)
Due: Feb 18, 2026 225 days

Basic Information

Serial Number
88279875
Registration Number
5987801
Deadline
February 18, 2026
Description
5 Year - Section 8 and 15 Renewal
Filing Date
January 28, 2019
Registration Date
February 18, 2020
Published for Opposition
August 6, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 18, 2020
Registration
Registered
Classes
005 042 044

Rights Holder

AFYX DEVELOPMENT A/S

65
Address
AGERN ALLE 24
H�RSHOLM 2970
DK

Ownership History

Dermtreat A/S

Original Applicant
99
København S DK

AFYX THERAPEUTICS A/S

New Owner Before Publication #1
65
KØBENHAVN S DK

AFYX THERAPEUTICS A/S

Owner at Publication
65
KØBENHAVN S DK

AFYX THERAPEUTICS A/S

Original Registrant
65
KØBENHAVN S DK

AFYX DEVELOPMENT A/S

New Owner After Registration #1
65
H�RSHOLM DK

Legal Representation

Attorney
Carolyn M. Gouges d'Agincourt

USPTO Deadlines

Next Renewal Deadline
225 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-02-18)
Due Date
February 18, 2026
Grace Period Ends
August 18, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

37 events
Date Code Type Description
Apr 16, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 25, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 25, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 25, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 25, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 25, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 25, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 6, 2024 WOAG I WITHDRAWAL OF ATTORNEY GRANTED
Dec 6, 2024 WOAR I TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Dec 6, 2024 EWOR I TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Dec 6, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 6, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 18, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 15, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 15, 2020 DP1B I 1(B) BASIS DELETED; PROCEED TO REGISTRATION
Nov 26, 2019 IUCN S NOTICE OF ALLOWANCE CANCELLED
Nov 26, 2019 D1BR I TEAS DELETE 1(B) BASIS RECEIVED
Oct 16, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 16, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 1, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 6, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2019 PUBO A PUBLISHED FOR OPPOSITION
Jul 17, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 10, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 28, 2019 FIXD O ELECTRONIC RECORD REVIEW COMPLETE
Jun 21, 2019 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 19, 2019 ALIE A ASSIGNED TO LIE
Jun 6, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 5, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 5, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 9, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 9, 2019 GNRT F NON-FINAL ACTION E-MAILED
Apr 9, 2019 CNRT R NON-FINAL ACTION WRITTEN
Apr 9, 2019 DOCK D ASSIGNED TO EXAMINER
Feb 20, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 31, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceuticals for treatment of mucosal diseases; pharmaceutical preparations and substances for treatment of mucosal diseases; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for treating mucous membrane disorders; pharmaceutical preparations, namely, muco adhesive patches for efficient and uniform drug release; medicine for treatment of mucosal diseases; medical preparations and articles for treatment of mucosal diseases; medical preparations and articles, namely, mucous membrane- and skin- adhesive patches for coverage of lesions and/or efficient and uniform drug delivery; patches for treatment of mucosal diseases; adhesive patches for medical purposes, namely for treatment of mucosal diseases; skin patches for the transdermal delivery of pharmaceuticals for use in the treatment of mucosal diseases; mucous membrane patches for the transdermal delivery of pharmaceuticals for use in the treatment of mucosal diseases; transdermal patches for use in the treatment of mucosal diseases; transdermal patches for medical treatment for use in the treatment of mucosal diseases; transmucosal patches for medical treatment of mucosal diseases; dressings, medical; adhesive dressings; dressings for wounds; bandages, medical; adhesive bandages; bandages for skin wounds; bandages for mucous membrane wounds; mucosal surface delivery of pharmaceuticals for use in the treatment of mucosal diseases
Class 042
Scientific, medical and pharmaceutical research and development services; research and development of pharmaceutical preparations; research and development of pharmaceutical preparations for treating skin disorders; research and development of pharmaceutical preparations for treating mucous membrane disorders; research and development of pharmaceutical preparations, namely, muco adhesive patches for efficient and uniform drug release; research and development of medicines; research and development of medical preparations and articles; research and development of medical preparations and articles, namely, mucous membrane- and skin- adhesive patches for coverage of lesions and/or efficient and uniform drug delivery; medical research and analysis services; biological research; clinical research in the field of treatment of mucosal diseases; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals
Class 044
Medical services; medical treatment services; medical screening; medical monitoring, testing, inspection and analysis services; medical services relating to the diagnosis and treatment of skin disorders; medical services relating to the diagnosis and treatment of mucous membrane disorders; pharmaceutical compounding services; pharmaceutical advisory services; dermatological services for treating skin conditions; dermatological services for treating mucous membrane conditions; laboratory analysis services relating to the diagnosis and treatment of skin disorders; medical laboratory analysis services provided by medical laboratories relating to the diagnosis and treatment of mucous membrane disorders

Classification

International Classes
005 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"